
Catalent swallows VMIC Ltd
The biologics development and manufacturing facility taken over from Vaccine Manufacturing and Innovation Centre UK Ltd. is locaterd n to the south...

AXA launches €440 m private equity healthcare strategy
The Strategy focuses specifically on companies in four core areas: medical devices, biopharmaceuticals, vaccines, and diagnostics. The...

Novo Holdings co-leads €40m Qure.ai financing
Qure.ai said it will use the proceeds from the $40m financing round to intesify product development for critical care and community...

ECBF oversubscribed closing at €300m
According to the industry experts, the biologisation of industrial production by means of sustainable bacterial-enzymatic or cell-culture-based...

Sanofi and IGM Biosciences Inc. in $6.15bn deal
Under the agreement, IGM Biosciences Inc. (Mountain View) will discover IgM antibody agonists against three oncology targets and...

Gilde Healthcare Private Equity IV launches €517m
The new oversubscribed fund will focus its investements on firms with an active buy-and-build strategy and is designed to invest in all sub-segments...